Jones Financial Companies Lllp Acquires 822 Shares of Humana Inc. (NYSE:HUM)

Jones Financial Companies Lllp boosted its holdings in Humana Inc. (NYSE:HUM) by 68.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,029 shares of the insurance provider’s stock after acquiring an additional 822 shares during the period. Jones Financial Companies Lllp’s holdings in Humana were worth $515,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. FPC Investment Advisory Inc. bought a new stake in shares of Humana during the fourth quarter worth approximately $27,000. Centricity Wealth Management LLC bought a new stake in Humana in the 4th quarter valued at $30,000. Ashton Thomas Securities LLC acquired a new position in Humana in the 3rd quarter valued at $31,000. Atwood & Palmer Inc. increased its position in Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after buying an additional 60 shares during the period. Finally, Kestra Investment Management LLC acquired a new stake in shares of Humana during the fourth quarter worth $49,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.32% of the stock is owned by company insiders.

Humana Stock Down 3.2 %

Shares of NYSE:HUM opened at $251.41 on Tuesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The business has a 50 day simple moving average of $271.74 and a two-hundred day simple moving average of $282.37. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The firm has a market capitalization of $30.33 billion, a PE ratio of 25.27, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.41%. Humana’s payout ratio is 35.58%.

Analyst Ratings Changes

Several brokerages have weighed in on HUM. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. StockNews.com cut Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Piper Sandler raised their price objective on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. JPMorgan Chase & Co. cut their target price on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research report on Tuesday, February 18th. Finally, Truist Financial raised their price target on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Twenty analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $285.68.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.